VANDENBULKE advised one of the US largest banks in relation to the issuance of USD 350,000,000 senior notes due 2022 with a yield of 9% by a NASDAQ listed healthcare company focused on legacy pharmaceutical products and orphan drugs.
/FINANCE/
VANDENBULKE advised one of the US largest banks in relation to the issuance of USD 350,000,000 senior notes due 2022 with a yield of 9% by a NASDAQ listed healthcare company focused on legacy pharmaceutical products and orphan drugs.